Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Johnson & Johnson (JNJ) had Consolidated Net Income/Loss of $11.00B for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$21.89B |
|
$11.00B |
|
$7.36B |
|
$14.54B |
|
$8.26B |
|
$13.63B |
|
-- |
|
$13.63B |
|
$13.63B |
|
$11.00B |
|
$11.00B |
|
|
Consolidated Net Income/Loss |
$11.00B |
$11.00B |
|
$13.76B |
|
-- |
|
-- |
|
2.42B |
|
-- |
|
$4.54 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|